Epigral Ltd. Capital Reinvestment Ratio
Epigral Ltd. capital reinvestment ratio. Epigral Ltd. (EPIGRAL) has a Capital Reinvestment Ratio of 0.88x as of September 2025, meaning it reinvests 1% of its operating cash flow (Rs2.67 Billion) in capital expenditures (Rs2.36 Billion). See free cash flow generation of Epigral Ltd. to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Epigral Ltd. (2015–2026)
Capital reinvestment ratio of Epigral Ltd. from 2015 to 2026. This chart tracks Epigral Ltd.'s Capital Reinvestment Ratio across 12 annual periods. See Epigral Ltd. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
Epigral Ltd. Capital Reinvestment Ratio by Year (2015–2026)
Epigral Ltd. capital reinvestment ratio by year from 2015 to 2026. For the full cash flow conversion analysis, see Epigral Ltd. cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2026 | 1.02x | Rs3.88 Billion | Rs3.94 Billion | ▲ +130.1% |
| 2025 | 0.44x | Rs4.41 Billion | Rs1.95 Billion | ▼ -55.9% |
| 2024 | 1.00x | Rs3.98 Billion | Rs3.98 Billion | ▲ +50.7% |
| 2023 | 0.67x | Rs6.26 Billion | Rs4.16 Billion | ▼ -58.6% |
| 2022 | 1.61x | Rs2.84 Billion | Rs4.56 Billion | ▲ +87.3% |
| 2021 | 0.86x | Rs2.29 Billion | Rs1.97 Billion | ▼ -61.7% |
| 2020 | 2.24x | Rs1.65 Billion | Rs3.69 Billion | ▲ +93.6% |
| 2019 | 1.16x | Rs2.61 Billion | Rs3.03 Billion | ▲ +110.9% |
| 2018 | 0.55x | Rs2.25 Billion | Rs1.23 Billion | ▲ +117.6% |
| 2017 | 0.25x | Rs1.38 Billion | Rs349.30 Million | ▼ -46.8% |
| 2016 | 0.47x | Rs1.23 Billion | Rs585.42 Million | ▲ +1443.4% |
| 2015 | 0.03x | Rs1.12 Billion | Rs34.48 Million | — |